Předmět: |
|
Zdroj: |
Clinical Trials Week; 6/19/2023, p359-359, 1p |
Abstrakt: |
For each 1 standard deviation (SD) increment in cumulative grip strength, the multivariable-adjusted OR for CVD and all -cause mortality were 0.81 (95% CI 0.73-0.91) and 0.85 (95% CI 0.73-0.99), respec-tively. Keywords: Nanjing; People's Republic of China; Asia; Cardiology; Cardiovascular; Cardiovascular Diseases and Conditions; Cardiovascular Research; Clinical Research; Clinical Trials and Studies; Health and Medicine; Risk and Prevention EN Nanjing People's Republic of China Asia Cardiology Cardiovascular Cardiovascular Diseases and Conditions Cardiovascular Research Clinical Research Clinical Trials and Studies Health and Medicine Risk and Prevention 359 359 1 06/19/23 20230619 NES 230619 2023 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators publish new report on Cardiovascular Diseases and Conditions. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|